Skip to main content
. 2022 Aug 20;12:14221. doi: 10.1038/s41598-022-18545-6

Table 2.

Characteristics of studies included only in the qualitative synthesis ND: no data.

Publication data GR 1 GR 2 Design Demography No. of patients Definition of clinical success Definition of recurrence Mean follow up (months)
First author Year of publication Country, institution Age (years) group surgical excision Female ratio % Group 1
Mean Standard deviation
Chaugule et al.36 2017 IFN 5-FU Retrospective, interventional series USA—The New York Eye Cancer Center ND ND ND 6 Clinical resolution of the tumor, defined on slit-lamp examination Reappearance of the lesion at a similar location, after complete resolution IFN: 8.8; 5-FU: 18
Kusumesh et al.37 2017 IFN MMC Retrospective, comparative study Patna, India—Cornea Services, Regional Institute of Ophthalmology, Indira Gandhi Institute of Medical Sciences 59.5 14.55 ND 51 Total disappearance of lesions with clear visibility of underlying structures Reappearance of a tumor at the same location or at any other location after complete resolution IFN: 22.2 MMC: 23.6
Venkateswaran et al.38 2018 IFN 5-FU Retrospective, comparative, interventional case series USA—University of Miami, Bascom Palmer Eye Institute 67.5 11 ND 102 Disappearance of the lesion clinically and/or by AS-OCT Reappearance of a tumor at the same/similar location or at any part of the ocular surface after complete resolution 5-FU: 15.8 IFN: 20.9